METASTATIC
Clinical trials for METASTATIC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC trials appear
Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation plus two immunotherapy drugs shows promise for tough cancers
Disease control CompletedThis early-phase trial looked at combining a special type of radiation (hypofractionated radiotherapy) with two immunotherapy drugs (MEDI4736 and tremelimumab) for people with advanced melanoma, lung, breast, or pancreatic cancer that had spread. The main goal was to find the saf…
Matched conditions: METASTATIC
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 17, 2026 00:43 UTC
-
Gene-Tailored drugs show promise for rare salivary gland cancer
Disease control CompletedThis study looked at whether giving people with advanced salivary gland cancer a drug that matches their tumor's genetic makeup can help control the disease. 114 participants first had their tumor genes analyzed. If a targetable change was found, they got a matched drug; if not, …
Matched conditions: METASTATIC
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New cell therapy trial targets Hard-to-Treat stage IV cancers
Disease control CompletedThis early-phase trial tested a combination of immune cells (cellular immunotherapy) in 9 people with stage IV solid tumors that had not responded to standard treatments. The main goal was to check safety and side effects, while also looking at whether the therapy could shrink tu…
Matched conditions: METASTATIC
Phase: PHASE1 • Sponsor: Seoul Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC